Your browser doesn't support javascript.
loading
Deferred treatment with sofosbuvir-velpatasvir-voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1.
Bourlière, Marc; Gordon, Stuart C; Schiff, Eugene R; Tran, Tram T; Ravendhran, Natarajan; Landis, Charles S; Hyland, Robert H; Stamm, Luisa M; Zhang, Jie; Dvory-Sobol, Hadas; Subramanian, G Mani; Brainard, Diana M; McHutchison, John G; Serfaty, Lawrence; Thompson, Alex J; Sepe, Thomas E; Curry, Michael P; Reddy, K Rajender; Manns, Michael P.
Afiliação
  • Bourlière M; Hépato-Gastroentérologie, Hôpital Saint Joseph, Marseille, France. Electronic address: mbourliere@hopital-saint-joseph.fr.
  • Gordon SC; Henry Ford Health System, Detroit, MI, USA.
  • Schiff ER; Schiff Center for Liver Diseases, University of Miami, Coral Gables, FL, USA.
  • Tran TT; Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Ravendhran N; Digestive Disease Associates, Catonsville, MD, USA.
  • Landis CS; Division of Gastroenterology and Hepatology, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Hyland RH; Gilead Sciences, Foster City, CA, USA.
  • Stamm LM; Gilead Sciences, Foster City, CA, USA.
  • Zhang J; Gilead Sciences, Foster City, CA, USA.
  • Dvory-Sobol H; Gilead Sciences, Foster City, CA, USA.
  • Subramanian GM; Gilead Sciences, Foster City, CA, USA.
  • Brainard DM; Gilead Sciences, Foster City, CA, USA.
  • McHutchison JG; Gilead Sciences, Foster City, CA, USA.
  • Serfaty L; Service d'Hépatologie, Hôpital Saint-Antoine, Paris, France.
  • Thompson AJ; St Vincent's Hospital and the University of Melbourne, Melbourne, Fitzroy, VIC, Australia.
  • Sepe TE; Liver Center, University Gastroenterology, Providence, RI, USA.
  • Curry MP; Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Reddy KR; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Manns MP; Medizinischen Hochschule, Hannover, Germany.
Lancet Gastroenterol Hepatol ; 3(8): 559-565, 2018 08.
Article em En | MEDLINE | ID: mdl-29859740

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 3_ND / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 2_enfermedades_transmissibles / 3_diarrhea / 6_digestive_diseases Assunto principal: Antivirais / Sulfonamidas / Carbamatos / Proteínas não Estruturais Virais / Hepatite C Crônica / Compostos Macrocíclicos / Sofosbuvir / Compostos Heterocíclicos de 4 ou mais Anéis Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Gastroenterol Hepatol Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 3_ND / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 2_enfermedades_transmissibles / 3_diarrhea / 6_digestive_diseases Assunto principal: Antivirais / Sulfonamidas / Carbamatos / Proteínas não Estruturais Virais / Hepatite C Crônica / Compostos Macrocíclicos / Sofosbuvir / Compostos Heterocíclicos de 4 ou mais Anéis Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Gastroenterol Hepatol Ano de publicação: 2018 Tipo de documento: Article
...